-
E168847-100mgEmodin 8-glucoside.
-
E168847-20mgEmodin 8-glucoside.
-
E168847-50mgEmodin 8-glucoside.
-
E664302-10mgEmodin-6-O-β-D-glucopyranoside.
-
E127439-100gEmpagliflozin (BI-10773) is a potent and selective SGLT-2 inhibitor with IC50 of 3.1 nM, exhibits >:300-fold selectivity over SGLT-1, 4, 5 and 6. Phase 3.
-
E127439-1gEmpagliflozin (BI-10773) is a potent and selective SGLT-2 inhibitor with IC50 of 3.1 nM, exhibits >:300-fold selectivity over SGLT-1, 4, 5 and 6. Phase 3.
-
E127439-250mgEmpagliflozin (BI-10773) is a potent and selective SGLT-2 inhibitor with IC50 of 3.1 nM, exhibits >:300-fold selectivity over SGLT-1, 4, 5 and 6. Phase 3.
-
E127439-25gEmpagliflozin (BI-10773) is a potent and selective SGLT-2 inhibitor with IC50 of 3.1 nM, exhibits >:300-fold selectivity over SGLT-1, 4, 5 and 6. Phase 3.
-
E127439-5gEmpagliflozin (BI-10773) is a potent and selective SGLT-2 inhibitor with IC50 of 3.1 nM, exhibits >:300-fold selectivity over SGLT-1, 4, 5 and 6. Phase 3.
-
E127439-5mgEmpagliflozin (BI-10773) is a potent and selective SGLT-2 inhibitor with IC50 of 3.1 nM, exhibits >:300-fold selectivity over SGLT-1, 4, 5 and 6. Phase 3.
-
E129418-100gEpiandrosterone.
-
E129418-1gEpiandrosterone.